Markers of liver fibrosis

Papers on markers of liver fibrosis

10 papers3 new in 30 days

Monday, November 2

Nutrition, Metabolism, and Cardiovascular DiseasesNov 2

Fibrosis-4 index and all-cause mortality in MASLD/NAFLD and cardiometabolic populations: a systematic review with structured synthesis without meta-analysis (SWiM)

Figure from Nutrition, Metabolism, and Cardiovascular Diseases

Meta-analysis of observational studiesFibrosis-4 Index

Monday, October 26

ESC Congress 2026 AbstractOct 26

Dynamic changes in liver fibrosis and the risk of death and bleeding in non-cirrhotic patients with atrial fibrillation treated with NOACs

Cohort study of 733 peopleLiver fibrosis

Tuesday, October 20

Naunyn-Schmiedeberg's Archives of PharmacologyOct 20

Anti-inflammatory versus metabolic therapy in MASLD: a randomized clinical trial of aspirin and dapagliflozin using fibroscan outcomes

Figure from Naunyn-Schmiedeberg's Archives of Pharmacology

Randomized trial in 80 peopleAspirin

Tuesday, March 17

Journal of Extracellular VesiclesMar 17

Circulating Liver-Derived and CD36⁺ Extracellular Vesicles Correlate With Ectopic Liver Fat and Markers of Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease and Decrease During Weight Loss Intervention

Non-randomized trial in peopleLiver fat content

Saturday, March 7

BMC GastroenterologyMar 7

Development of a liver stiffness measurement-based nomogram model to identify early CKD risk in patients with MAFLD

Cohort study of 1,328 peopleLiver stiffness measurement

Wednesday, November 5

Geriatrics & Gerontology InternationalNov 5

The Role of an Elevated Fibrosis-4 Index in Neurocognitive Decline and Brain Volume Reduction in Older Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease

Cross-sectional study of 384 peopleMetabolic dysfunction-associated steatotic liver disease

Saturday, July 5

Hepatology ResearchJul 5

Effect of Tirzepatide Treatment on Hepatic Biomarkers in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease and Type 2 Diabetes Mellitus

Non-randomized trial in 16 peopleTirzepatide

Monday, February 10

Journal of Diabetes and Metabolic DisordersFeb 10

Association between liver fibrosis and osteoporosis in adults aged 50 and older: insights from the Bushehr Elderly Health Program

Cross-sectional study of 1,959 peopleLiver fibrosis

Monday, January 6

European Journal of Pharmaceutical SciencesJan 6

Activation of SIRT1 by SRT1720 alleviates dyslipidemia, improves insulin sensitivity and exhibits liver-protective effects in diabetic rats on a high-fat diet: New insights into the SIRT1/Nrf2/NFκB signaling pathway

Experiments in ratsDyslipidemia

Sunday, July 24

Aging CellJul 24

Senolytic treatment reduces cell senescence and necroptosis in Sod1 knockout mice that is associated with reduced inflammation and hepatocellular carcinoma

Experiments in miceSenolytics